Design, Synthesis, and Evaluation of Benzimidazole‐Carbazole Hybrids Targeting Heat Shock Proteins‐Mediated Apoptosis in Breast and Colon Cancer Cells
Drug Development Research · 2025
DOI: 10.1002/ddr.70092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, 2025. Verfasst von İrfan Çapan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Basic Sciences, Faculty of Pharmacy, Gazi University, Ankara, Turkey. Hauptthemen laut MEDLINE: Benzimidazoles, Apoptosis, Carbazoles, Breast Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: This study was supported by The Scientific and Technological Research Council of Turkey (TUBITAK Project No. 119Z561)..
Abstract (Originalsprache)
Heat shock proteins (HSPs), particularly HSP70 and HSP90, are pivotal molecular chaperones implicated in cancer progression and resistance mechanisms. Dual inhibition of these chaperones represents a promising therapeutic approach. Here, we report the design and synthesis of a novel series of benzimidazole‐carbazole hybrids aimed at targeting HSP70/90. Leveraging the kinase inhibitory properties of benzimidazole and the DNA interfering and apoptotic potential of carbazole, these hybrids were evaluated for their anticancer activity against breast (MCF‐7) and colon (HCT‐116) cancer cell lines. The most active compounds demonstrated submicromolar IC 50 values and induced apoptosis through mitochondrial dysfunction and cytoskeletal disruption, confirmed via flow cytometry and fluorescence microscopy. Molecular docking revealed high binding affinities to HSP70 (PDB: 1S3X) and HSP90 (PDB: 1YC4), correlating with experimental outcomes. Furthermore, DNA interaction studies confirmed the compounds' ability to induce structural destabilization and fragmentation, providing insight into their mechanism of action. These findings highlight the potential of benzimidazole‐carbazole hybrids as promising HSP inhibitors for overcoming cancer resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Basic Sciences, Faculty of Pharmacy, Gazi University, Ankara, Turkey.
- Sente Kimya Research and Development Inc, Ankara, Turkey.
- Department of Basic Medical Sciences, Division of Medicinal Biochemistry, University of Health Sciences, Istanbul, Turkey.
- Akdağmadeni Health College, Yozgat Bozok University, Yozgat, Turkey.
- Department of Biology, Faculty of Science, Gazi University, Ankara, Turkey.
- Division of Molecular Biology and Genetics, Faculty of Hamidiye Institute of Health Sciences, University of Health Sciences, İstanbul, Turkey.
ORCID-Profile: İrfan Çapan
Förderung
- This study was supported by The Scientific and Technological Research Council of Turkey (TUBITAK Project No. 119Z561).
Zitieren
APA
Çapan, İ., Al, M., Gümüş, M., Açik, L., Aydin, B., Çelik, A. B., Gülüm, L., Sert, Y., Yenilmez, E. N., Koca, İ., & Tutar, Y. (2025). Design, Synthesis, and Evaluation of Benzimidazole‐Carbazole Hybrids Targeting Heat Shock Proteins‐Mediated Apoptosis in Breast and Colon Cancer Cells. Drug Development Research. https://doi.org/10.1002/ddr.70092
Vancouver
Çapan İ, Al M, Gümüş M, Açik L, Aydin B, Çelik AB, et al. Design, Synthesis, and Evaluation of Benzimidazole‐Carbazole Hybrids Targeting Heat Shock Proteins‐Mediated Apoptosis in Breast and Colon Cancer Cells. Drug Development Research. 2025. doi:10.1002/ddr.70092
BibTeX
@article{apan2025,
author = {Çapan, İrfan and Al, Mervenur and Gümüş, Mehmet and Açik, Leyla and Aydin, Betül and Çelik, Ayşe Büşranur and Gülüm, Levent and Sert, Yusuf and Yenilmez, Ezgi Nurdan and Koca, İrfan and Tutar, Yusuf},
title = {Design, Synthesis, and Evaluation of Benzimidazole‐Carbazole Hybrids Targeting Heat Shock Proteins‐Mediated Apoptosis in Breast and Colon Cancer Cells},
journal = {Drug Development Research},
year = {2025},
doi = {10.1002/ddr.70092}
}
EUVIMED